Hypothyroidism and 131I Therapy

BMJ
doi 10.1136/bmj.3.5613.314-a
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Thyroid and Hepatic Function After High-Dose 131i-Metaiodobenzylguanidine (131i-Mibg) Therapy for Neuroblastoma

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2010English

Toxicity of Upfront 131i-Metaiodobenzylguanidine (131i-Mibg) Therapy in Newly Diagnosed Neuroblastoma Patients: A Retrospective Analysis

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2013English

Therapy of Cervical Cancer Using 131i-Labeled Nanoparticles

Journal of International Medical Research
BiochemistryMedicineCell Biology
2018English

Improving 131I Radioiodine Therapy by Hybrid Polymer-Grafted Gold Nanoparticles

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2019English

Current Concepts of 131I Therapy in Oncology: Indications, Methods and Follow Up

Archive of Oncology
OncologyHematology
2006English

Radiation Exposure From Outpatient Radioactive Iodine (131I) Therapy for Thyroid Carcinoma

JAMA - Journal of the American Medical Association
Medicine
2000English

Levothyroxine Therapy Affects Cerebral Blood Flow and Fatigue in Subclinical Hypothyroidism

Endocrine Abstracts
2013English

Yagya Therapy for Sub-Clinical Hypothyroidism: A Case Study

Interdisciplinary Journal of Yagya Research
2018English

Long-Term Results of Radioiodine (131I) Therapy in 331 Patients With Graves' Disease.

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1980English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy